Document |
Document Title |
WO/2017/018425A1 |
The present invention relates to a method for producing a medical device and a medical device. The production method comprises a step for heating a device together with a liquid containing a polymer having repeating units (A) and repeati...
|
WO/2017/016367A1 |
An iron based and absorbable implanted prefabricated tube (1) for medical device and preparation method therefor, and a medical device prepared by the prefabricated tube and preparation method therefor. The average content of nitrogen in...
|
WO/2017/011321A1 |
A method for producing an antimicrobial coating on a surface. The method includes mixing a parylene dimer and an antimicrobial agent to form a mixture, heating the mixture to sublimate the parylene dimer and suspend the antimicrobial age...
|
WO/2017/007430A1 |
Disclosed herein is a drug-coated medical device in the form of a balloon having an inner surface and an outer hydrophobic surface, an adhesion balance layer directly on the outer hydrophobic surface of the balloon, comprising a hydrophi...
|
WO/2016/206078A1 |
A method for preparing a drug balloon comprises the following steps: (1) preparing a particle coating at a surface of a balloon, wherein the particle coating is made of sodium chloride, calcium chloride or urea; (2) placing the balloon h...
|
WO/2016/205018A1 |
A water disintegratable catheter having a barrier layer disposed on an outer surface and/or inner surface of the catheter wherein the barrier layer comprises a hydrophobic component.
|
WO/2016/204217A1 |
Provided is a novel biocompatible material having improved biocompatibility. A biocompatible material comprising a fluoropolymer, said biocompatible material being characterized in that the fluoropolymer is a copolymer of a fluoroolefin ...
|
WO/2016/205383A1 |
Polymeric materials that are blends of polymers having differing water solubility rates are disclosed. The blends may be incorporated into at least a portion of a medical devices such as the shafts of flushable urinary catheters to provi...
|
WO/2016/200337A1 |
Described herein are coatings and formulations thereof for coating a substrate for use in producing a lubricious coating on a substrate surface that is to be inserted into the body lumen of a subject. Said coatings all contain an adhesio...
|
WO/2016/200956A1 |
The present invention provides silicon-based polycarbonates, processes for their preparation and their use in the synthesis of copolymers, in particular segmented copolymers such as polyurethanes for biomedical applications.
|
WO/2016/196511A1 |
Methods and devices described for improved dynamic walled tubing and catheters.
|
WO/2016/196447A1 |
A balloon for a medical device is made from a biocompatible material including a base resin polymer and at least one additive totaling 1.0% or less by weight of the base resin polymer.
|
WO/2016/187454A1 |
Devices prepared from polyetherimide resins are disclosed. In one aspect, the article can be medical device configured for use in a body or relating to a medical operation.
|
WO/2016/181245A1 |
The present disclosure relates to a coating for medical devices. The lubricious coating includes a primer layer and a top coating layer as well as methods of making and using the same. The primer layer includes a reaction cured product o...
|
WO/2016/183421A1 |
In embodiments, medical devices, such balloon catheters or stents, can deliver a therapeutic agent to body tissue of a patient. The medical device a therapeutic coating comprising a polydopamine coated therapeutic agent disposed on a sur...
|
WO/2016/172343A1 |
Embodiments of the present invention provide a method of treating a stricture in a nonvascular body lumen such as urethral strictures, benign prostatic hyperplasia (BPH) strictures, ureteral strictures, esophageal strictures, sinus stric...
|
WO/2016/172460A1 |
A surface-modified polymer composition formed from an oligomeric or polymeric additive and a base polymer is disclosed. The surface-modified polymer provides non-fouling and/or non-thrombogenic properties. The composition is particularly...
|
WO/2016/165731A1 |
A tube (10; 10'; 10") for a medical container has a tube wall which consists of at least two layers. According to the invention, at least one layer contains a styrene-containing thermoplastic polymer (S-TPE), in particular a styrene-buta...
|
WO/2016/168121A1 |
Processing methods are described for improving the physical properties of elastomeric materials including elastomeric tubing. The methods include heating tubing in a post-cured step for a specified time and at a specified temperature. Th...
|
WO/2016/165942A1 |
A tube (10; 10'; 10") for a medical container has a tube wall which consists of at least two layers. According to the invention, at least one layer contains a styrene-containing thermoplastic polymer (S-TPE), in particular a styrene-buta...
|
WO/2016/160983A1 |
Invasive medical devices including a substantially non-eluting antimicrobial treatment are disclosed. One or more external and/or internal surfaces of the medical device include a substantially non-eluting copper-coated surface that assi...
|
WO/2016/160446A1 |
An immunotherapy delivery device is provided including a catheter and a pressure modulating device fixed adjacent the distal end of the catheter. In accord with aspects of the device, the lumen of the catheter is coated to facilitate del...
|
WO/2016/159885A1 |
There is provided a controlled-release antibiotic socket for securely holding an implantable medical device that is made from: at least one film having at least one polymer layer, where the at least one film is formed into the socket; at...
|
WO/2016/158700A1 |
The present invention provides a medical instrument having a lubricating layer that reduces the association of polymer brushes while ensuring hemocompatibility. This medical instrument has a base material layer and a lubricating layer co...
|
WO/2016/154541A1 |
A biocompatible polymeric controlled release matrix barrier structure for delivery of one or more bioactive agents from an implantable medical device is described. In an embodiment, a biocompatible polymeric controlled release matrix bar...
|
WO/2016/149193A1 |
A bi-metal medical guidewire with a core wire having a stainless steel proximal section and Nitinol distal section offers performance enhancements compared to guidewires made from either alloy alone. A solid-state, frictional welding or ...
|
WO/2016/147191A1 |
Aspects of disclosed embodiments relate to systems, devices and methods for treating and preventing restenosis by cross-linking collagen fibrils of the vessel wall at the intervention site. The devices described are drug-eluting devices ...
|
WO/2016/143787A1 |
The present invention addresses the problem of providing a block copolymer that has excellent adhesion to a substrate and can provide excellent antithrombogenicity to a surface of the substrate, and a medical device using the block copol...
|
WO/2016/138558A1 |
The present invention relates to a method of adversely affecting a biofilm, the method comprising exposing the biofilm to a composition comprising an effective amount of polymer that incorporates within its backbone structure a first pol...
|
WO/2016/135349A1 |
Phase segregated block-copolymer based on repeating structural elements represented by formula (I) wherein PHA represents at least one block based on one or more a-hydroxy acids, PDAS represents a central block based on a dialkylsiloxane...
|
WO/2016/132597A1 |
Provided is a resin composition characterized by containing a resin, a light-emitting substance, and a radiopaque substance, wherein the content of the radiopaque substance is 2 mass% to 80 mass%. Also provided is any of the abovemention...
|
WO/2016/128620A1 |
The present invention relates to the use of nanofibrillar cellulose hydrogel in cell culture and medical applications. The invention relates to a composition comprising nanofibrillar cellulose, cross linkable polymer and at least one bio...
|
WO/2016/126882A1 |
Methods and devices are provided herein for surfaces for de novo nucleic acid synthesis which provide for low error rates. In addition, methods and devices are provided herein for increased nucleic acid mass yield resulting from de novo ...
|
WO/2016/122894A1 |
Inserts can be formed with elution characteristics to cause the inserts to elute an antimicrobial agent when subject to a fluid within a medical device. An insert can be formed with a desired geometry to allow the insert to be compressio...
|
WO/2016/123480A1 |
Embodiments of the invention include drug delivery coatings and devices including the same. In an embodiment, the invention includes a drug delivery coating including a polymeric layer. The polymeric layer can include a hydrophilic outer...
|
WO/2016/118569A1 |
A catheter having a shaft made from polyvinyl alcohol where in the shaft has a varying stiffness along the length of the shaft.
|
WO/2016/114243A1 |
The present invention provides a thermoplastic elastomer (TPE), in particular a polyurethane-based thermoplastic elastomer (TPU), that has exceptional elongation, strength, and wear resistance, and in particular has exceptional wear resi...
|
WO/2016/109412A1 |
In one aspect, the present disclosure provides microparticles that are configured to release a first drug over a first time period and to release a second drug over a second time period, wherein a lag period of substantially no drug rele...
|
WO/2016/094622A1 |
Antimicrobial formulations and coatings for medical devices and processes therefor are disclosed. The formulations include at least one water permeable polymer with at least one antimicrobial agent in a liquid medium and are prepared by ...
|
WO/2016/091365A1 |
The present invention relates to a drug eluting device for preventing and treating restenosis and neointimal formation after vascular procedures and/or implantation of implants comprising an implantable or non-implantable device, such as...
|
WO/2016/094533A1 |
Medical devices with a hydrogel layer covalently attached to a portion of the outer surface of the medical device are provided along with methods for applying the coating. The hydrogel layer can include a first polymer species comprising...
|
WO/2016/084716A1 |
The present invention provides a medical instrument having a coating layer (lubrication layer) that exhibits exceptional lubricity and durability. This medical instrument is provided with a base material layer and a lubrication layer sup...
|
WO/2016/083351A1 |
The invention relates to a method for producing a storable molded body made of bacterial cellulose and a molded body produced according to the method. The method comprises the steps of: i) providing a molded body made of bacterial cellul...
|
WO/2016/080155A1 |
The present invention provides: an alloy material which comprises palladium and 10.2-50.0 mass% iridium, the alloy material being an improvement over conventional palladium alloys, having improved X-ray impermeability and better machinab...
|
WO/2016/076707A2 |
Described is an object surface coating comprising one or more polymers and a peptide covalently linked to at least one of said one or more polymers, said peptide comprising a) a first cleavage site, wherein said first cleavage site is cl...
|
WO/2016/069640A1 |
A nested balloon is provided where each balloon is formed from tubing that optimizes the inner wall stretch thus providing maximum balloon strength. The high pressure, nested balloon is provided with layers that allow for slipping, such ...
|
WO/2016/068523A2 |
The present invention relates to a composition, containing a fat-soluble additive, for coating a balloon catheter, a balloon catheter coated with the composition for coating, and a method for manufacturing a drug-eluting balloon catheter...
|
WO/2016/068228A1 |
[Problem] To provide a carrier for sustained drug release that has a higher gelation speed, improved sustained release action and higher introduction efficiency into cells compared with conventional carriers for sustained release that co...
|
WO/2016/067795A1 |
[Problem] To provide: a material that is nonadhesive to biological substances, said material being capable of inhibiting or preventing adhesion of biological substances such as cells and blood components; a curing composition that is usa...
|
WO/2016/061186A1 |
The present disclosure is directed toward a composite balloon comprising a layer of material having a porous microstructure (e.g., ePTFE or expanded polyethylene) and a thermoplastic polymeric layer useful for medical applications. The l...
|